Boutros, Céline
Belkadi-Sadou, Djaouida
Marchand, Antoine
Roy, Séverine
Routier, Emilie
Robert, Caroline http://orcid.org/0000-0002-9493-0238
Article History
Accepted: 3 May 2023
First Online: 2 June 2023
Declarations
:
: Djaouida Belkadi-Sadou, Antoine Marchand, and Severine Roy declare no conflict of interest. Celine Boutros has received travel fees from Pierre Fabre, Amgen, and MSD, and has received compensation from MSD for participation in conferences, and from BMS for participation to advisory boards. Emilie Routier has received compensation from BMS, Novartis, and Pierre Fabre, and conference fees from BMS, Novartis, and Pierre Fabre. Caroline Robert reports consultancy for BMS, Roche, Novartis, Pierre Fabre, MSD, Sanofi, AstraZeneca, and Merck, and is cofounder of Ribonexus.